FDA Drug/Biologics Approval BLA 125160 S-283, CERTOLIZUMAB PEGOL

FDA Drug/Biologics Approval BLA 125160 S-283, CERTOLIZUMAB PEGOL

Regular price $149.00 USD
Regular price Sale price $149.00 USD
Sale Sold out
BLA 125160 S-283
Company: UCB INC
Drug Name: CIMZIA
Active Ingredients: CERTOLIZUMAB PEGOL
Strength: 200MG
Dosage Form/Route: INJECTABLE; INJECTION
Action Date: 04/22/2008
Marketing Status: Prescription
Submission Classification: ORIG-1

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details